Breen Michael Martin 4
4 · GT Biopharma, Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Breen Michael Martin
Director
Transactions
- Award
Option to purchase Common Stock
2023-01-27+500,000→ 500,000 totalExercise: $0.84Exp: 2033-01-26→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct, and the reporting person is involuntarily terminated by the registrant.